DEF 14APYXSCIK 0001782223

Pyxis Oncology, Inc.

Name: SEC EDGAR filing 0001193125-26-194032
Creator: Pyxis Oncology, Inc.
License: https://www.usa.gov/government-works

Proxy statement (DEF 14A) filed April 30, 2026.

Definitive proxy statement disclosing matters to be voted on by shareholders, including executive compensation.

Read the filing on SEC.gov All documents in this filing

New to the DEF 14A? What it is and how to read one

Filing facts

Accession number: 0001193125-26-194032
Filer: Pyxis Oncology, Inc.
Ticker: PYXS
CIK: 0001782223
Form type: DEF 14A
Form description: Proxy statement
Filed at: April 30, 2026
Period of report: April 30, 2026
Industry: SIC 2834Pharmaceutical Preparations
Filing size: 1.7 MB
Last verified: August 26, 2026SecFilingDex pulls from EDGAR with daily cadence

More filings from Pyxis Oncology, Inc.

See all 45 filings from Pyxis Oncology, Inc. →

Provenance

Authoritative source — SEC EDGAR

https://www.sec.gov/Archives/edgar/data/1782223/000119312526194032/0001193125-26-194032-index.htm ↗

Filer's full EDGAR submission history

EDGAR · Pyxis Oncology, Inc. (0001782223) ↗

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.